Apollon Formularies - Directors’ Dealing

RNS Number: 1849 Z Apollon Formularies plc 13 September 2022 13 September 2022. Apollon Formularies plc, a UK based international pharmaceutical company trading on the Aquis Stock Exchange, announces that it has been notified on 13 th of September 2022, that Roderick Claude McIllree, Non-Executive Director, has transferred 10,000,000 Ordinary Shares for...